Aspen Neuroscience Inc. (ASPE) Stock Price & Fundamentals
Data as of Nov 16, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)
Aspen Neuroscience, Inc. is a clinical-stage regenerative medicine biotechnology company, which engages in the development of autologous induced pluripotent stem cell (iPSC)-derived therapies to address neurodegenerative diseases.
Valuation
Financials & Margins
Peer Comparison
Ownership
For Aspen Neuroscience Inc., insiders hold 17.17% of the shares, institutions hold 52.15%, according to the latest holder filings.
Filings & documents
Aspen Neuroscience Inc. (ASPE) reports filed with the US Securities and Exchange Commission, newest first. SEC CIK 0002124080. Links open sec.gov.
Recent events (8-K)
- Charter or bylaw amendment; Other events8-K
Source: SEC EDGAR, checked 16 Nov 2026. All filings on SEC EDGAR
Latest News
About Aspen Neuroscience Inc.
Aspen Neuroscience, Inc. is a clinical-stage regenerative medicine biotechnology company, which engages in the development of autologous induced pluripotent stem cell (iPSC)-derived therapies to address neurodegenerative diseases. Its product candidate, sasineprocel, is an investigational single-dose, autologous iPSC-based cell therapy for the treatment of Parkinson's disease (PD). The company was founded by Jeanne F. Loring and Andrés Bratt-Leal in 2018 and is headquartered in San Diego, CA.
Aspen Neuroscience Inc. is headquartered in US.
Aspen Neuroscience Inc. (ASPE) stock trades at $12.10 with a market capitalization of $351.84M. Over the past 52 weeks the stock has ranged between $11.20 and $14.90, and currently trades 18.8% below its 52-week high.
Official website: www.aspenneuroscience.com
Aspen Neuroscience Inc. (ASPE) — frequently asked questions
What is Aspen Neuroscience Inc. (ASPE) stock price today?
Aspen Neuroscience Inc. (ASPE) is currently trading at $12.10, down 3.9% today.
What is Aspen Neuroscience Inc.'s market cap?
Aspen Neuroscience Inc. has a market capitalization of $351.84M.
How much debt does ASPE carry?
Aspen Neuroscience Inc. has a debt-to-equity ratio of 0.11. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is ASPE's profit margin?
Aspen Neuroscience Inc. reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.
What sector is ASPE in?
Aspen Neuroscience Inc. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is ASPE listed on?
Aspen Neuroscience Inc. trades on NASDAQ under the ticker ASPE.
What is ASPE's 52-week range?
Over the last year Aspen Neuroscience Inc. has traded between $11.20 and $14.90.
Related Healthcare Stocks
Popular Stocks
Screens ASPE currently matches
On the figures above, Aspen Neuroscience Inc. passes the filters for 5 of our ready-made screens, among them Small Cap Stocks, Stocks Under $100, Stocks Under $50. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.